Breaking News

Thermo Fisher Scientific To Acquire One Lamda

Will become part of Thermo’s Specialty Diagnostics Segment

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Thermo Fisher Scientific, Inc. has signed a definitive agreement to acquire One Lambda, a provider of transplant diagnostics, for $925 million in cash. The acquisition includes the cost of a three-year retention program for One Lambda’s key employees, and a one-year earn-out provision based on the achievement of certain financial targets. The transaction is expected close 4Q12. One Lambda is privately held and has approximately 320 employees, in Canoga Park, CA. The business generated revenu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters